RBC Capital Downgrades Aardvark Therapeutics Inc (AARD) to Sector Perform Mar 2, 2026 12:41AM
Aardvark Therapeutics Inc (AARD) PT Lowered to $18 at RBC Capital Nov 14, 2025 04:30AM
Aardvark Therapeutics Inc (AARD) PT Lowered to $19 at RBC Capital Aug 14, 2025 10:48AM
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May May 7, 2025 04:05PM
RBC Capital on Aardvark Therapeutics Inc (AARD): 'We See Substantial Upside Potential On Positive Data' Apr 1, 2025 08:18AM


Mar 10, 2025 06:23AM RBC Capital Starts Aardvark Therapeutics Inc (AARD) at Outperform
Feb 12, 2025 10:38PM Aardvark Therapeutics Announces Pricing of Initial Public Offering
Jan 23, 2025 05:01PM Aardvark Therapeutics (AARD) Files for Proposed IPO